NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Emory University
University of Texas Southwestern Medical Center
Providence Health & Services
Memorial Sloan Kettering Cancer Center
Oslo University Hospital
The Netherlands Cancer Institute
The Netherlands Cancer Institute
OHSU Knight Cancer Institute
Centre Leon Berard
Fondazione per la Medicina Personalizzata
Northwestern University
Memorial Sloan Kettering Cancer Center